Insulin cost caps help some commercially insured adults, but many insulin users remain unprotected
New Diabetes Care research explains why state insulin cost caps help some people, but leave...
Inflammation and Heart-Failure Risk in Type 2 Diabetes: What the Look AHEAD Study Found
New Look AHEAD findings connect IL-6 with heart-failure risk in type 2 diabetes, but do...
Human vs Analogue Insulin in Young People With Type 1 Diabetes: What the HumAn-1 Trial Found
The HumAn-1 trial found no clear CGM advantage for glargine over usual-care human insulin regimens...
HIIT for Diabetes: Benefits, Limits, and Safety Checks
HIIT may help fitness and glucose for some people with diabetes, but it is not...
Heart Health and Type 2 Diabetes: What New Research Says About Modern Diabetes Medications
A new review of 133 randomized trials explains how modern type 2 diabetes medication classes...
GLP-1 and Incretin Medicines: New Consensus Highlights Nutrition, Muscle, and Mental Health Support
A Lancet Diabetes & Endocrinology consensus statement highlights nutrition, muscle, function, GI symptoms, and psychological...
Global Diabetes Trends: Key Statistics and Patient Takeaways
Key WHO diabetes statistics, what the historical data means, why dates matter, and why treatment...
Gestational Diabetes and Flash Glucose Monitoring: What a New Randomized Trial Found
A randomized trial found that adding flash glucose monitoring did not improve glycaemic control in...
Flash Glucose Monitoring and Hospitalizations in Insulin-Treated Type 2 Diabetes: What a New Real-World Study Found
A 15,413-person real-world study linked publicly funded flash glucose monitoring with fewer acute diabetes-related hospitalizations...